查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529723

植入式心率管理设备市场规模、份额和趋势分析报告：按产品、最终用途、地区、细分市场预测，2024-2030 年

Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End-use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

植入式心率管理设备市场成长与趋势：

Grand View Research最新报告显示，到2030年，全球植入式心率管理设备市场规模预计将达到155.3亿美元，2024年至2030年复合年增长率为6.4%。

全球老化人口不断增加，容易患心血管疾病，以及对这些疾病准确有效诊断的需求正在推动植入式心律管理 (CRM) 设备的成长。

心臟病是全世界死亡的主要原因之一，很大一部分人一生中都会患有某种形式的心臟病。虽然老年人的风险较高，但年轻人心血管疾病的盛行率正在增加。繁忙的日程和忙碌的生活方式是导致个体高血压的主要因素。各种植入式装置用于改善心臟功能，包括心律调节器、ICD 和心臟再同步治疗 (CRT)。心律调节器是治疗传导障碍和鼻窦功能障碍最常用的植入设备。 CRT 和 ICD 相对较新，并且采用了比其前身更好的技术。

COVID-19大流行对市场尤其是ICD市场产生了负面影响，导致2020年需求和销售疲软。随着医院恢復择期手术，销售额有所改善。然而，几个主要市场持续爆发的 COVID-19 疫情全年继续带来不确定性。例如，雅培报告 2020 年第二季和第三季医院业务有所改善。然而，随着许多国家的 COVID-19 病例和住院人数激增，2020 年第四季的改善趋势趋于稳定或受到负面影响。同时，儘管销售活动因疫情而受到限制，但日本光电工业(工业 Industries) 的心臟去颤器销售在 2020 年仍呈现强劲成长。

心臟疾病是全世界死亡的主要原因之一，大多数人一生中都会患有某种形式的心臟疾病。儘管老年人的风险较高，但年轻人中心血管疾病的盛行率正在增加。各种植入式装置用于改善心臟的性能，包括心律调节器、ICD 和心臟再同步治疗 (CRT) 装置。植入式心律调节器主要用于传导障碍和鼻窦功能障碍。

植入式心率管理设备市场报告亮点

  • 2023 年，医院最终用途细分市场的收益占有率最大，超过 68.9%。这一增长是由更深的产品渗透、大量外科手术和患者数量的增加所推动的。
  • ICD产品领域在2023年占据最大的收益占有率。心臟再同步治疗设备领域预计将在预测期内实现最快的成长率。
  • 据估计，有 8570 万美国（或近 34% 的人口）患有高血压或由于生活方式紧张而患有高血压。 2017 年，近 2,340 万美国成年人被诊断出患有糖尿病，估计还有 760 万美国成年人患有未确诊的糖尿病。到 2030 年，全球糖尿病盛行率预计将增至 7.7%。
  • 由于已开发国家实施了支持性立法政策、提高了产品使用意识并增加了培训计划，预计 CRT 产品领域将在预测期内实现最快的成长率。
  • 北美地区在 2023 年占据市场主导地位，收益占有率将超过 47.6%。这是由于心血管疾病的盛行率不断上升、政府的支持性政策、有利的报销制度、意识的提高以及培训计画的数量不断增加。
  • 由于心血管疾病的高发生率和人口的快速老化，预计亚太地区在预测期内将出现最快的复合年增长率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球植入式心率管理设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 植入式心率管理设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 植入式心率管理设备市场：依产品估计与趋势分析

  • 植入式心率管理设备市场：依产品分類的仪表板
  • 植入式心率管理设备市场：依产品分類的差异分析
  • 2018-2030 年按产品分類的植入式心率管理设备市场规模、预测与趋势分析
  • 心律调节器
  • ICD
  • 阴极射线管

第五章植入式心率管理设备市场：最终用途的估计和趋势分析

  • 植入式心率管理设备市场：依最终用途分類的仪表板
  • 植入式心率管理设备市场：最终用途的变化分析
  • 2018-2030 年植入式心率管理设备市场规模、预测与趋势分析（依最终用途）
  • 医院
  • 专业心臟中心
  • 其他的

第六章 植入式心率管理设备市场：按国家、产品、最终用途和最终用途进行的区域估计和趋势分析

  • 全球植入式心率管理设备市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • Zoll Medical Corporation
    • Biotronik
    • Stryker
    • Schiller AG
    • Nihon Kohden Corporation
    • Microport Scientific Corporation
Product Code: GVR-2-68038-882-4

Implantable Cardiac Rhythm Management Devices Market Growth & Trends:

The global implantable cardiac rhythm management devices market size is expected to reach USD 15.53 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, The increasing global geriatric population prone to CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing to the growth of implantable cardiac rhythm management (CRM) devices.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.

The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.

Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.

Implantable Cardiac Rhythm Management Devices Market Report Highlights:

  • The hospital's end-use segment captured the largest revenue share of over 68.9% in 2023. The growth can be attributed to deeper product penetration, a large volume of surgical procedures, and rising patient footfall
  • The ICDs product segment held the largest revenue share in 2023. The cardiac resynchronization therapy devices segment is expected to register the fastest growth rate over the forecast period
  • An estimated 85.7 million Americans (i.e., almost 34% of the population) suffered from high blood pressure and hypertension due to stressful lifestyles. Almost 23.4 million American adults were diagnosed with diabetes in 2017, while an estimated additional 7.6 million American adults are undiagnosed diabetics. Globally, the prevalence of diabetes is expected to increase to 7.7% in 2030
  • The CRT product segment is anticipated to register the fastest growth rate over the forecast period due to the implementation of supportive legislative policies in developed countries and an increase in awareness and the number of training programs for use of the products
  • North America dominated the market with a revenue share of over 47.6% in 2023. This can be attributed to an increase in the incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and an increase in the number of training programs
  • Asia Pacific is expected to exhibit the fastest CAGR during the forecast period due to the higher prevalence of CVDs and rapidly aging population

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End-use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Implantable Cardiac Rhythm Management Device Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of arrhythmia disorders
      • 3.2.1.2. Technological advancements in device functionality
      • 3.2.1.3. Rising Heart failure (HF) cases
      • 3.2.1.4. Growing geriatric population
      • 3.2.1.5. Favorable reimbursement policies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Regulatory Policies
  • 3.3. Implantable Cardiac Rhythm Management Device Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Implantable Cardiac Rhythm Management Device Market: Product Estimates & Trend Analysis

  • 4.1. Implantable Cardiac Rhythm Management Device Market: Product Dashboard
  • 4.2. Implantable Cardiac Rhythm Management Device Market: Product Movement Analysis
  • 4.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Pacemaker
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Conventional Pacemakers
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Leadless Pacemaker
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. ICDs
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Single Chamber ICDs
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Dual Chamber ICDs
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. CRT
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.6.2. CRT-Defibrillator
      • 4.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.6.3. CRT-Pacemaker
      • 4.6.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Implantable Cardiac Rhythm Management Device Market: End-use Estimates & Trend Analysis

  • 5.1. Implantable Cardiac Rhythm Management Device Market: End-use Dashboard
  • 5.2. Implantable Cardiac Rhythm Management Device Market: End-use Movement Analysis
  • 5.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Specialty Cardiac Centers
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Implantable Cardiac Rhythm Management Device Market: Regional Estimates & Trend Analysis by Country, Product, End-use, & End-use

  • 6.1. Global Implantable Cardiac Rhythm Management Device Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. End-use benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. End-use benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Boston Scientific Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. End-use benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Koninklijke Philips N.V.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. End-use benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Zoll Medical Corporation
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. End-use benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Biotronik
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. End-use benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Stryker
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. End-use benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Schiller AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. End-use benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Nihon Kohden Corporation
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. End-use benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Microport Scientific Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. End-use benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Global implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global implantable CRM devices market, by end-use, 2018 - 2030
  • Table 5 Global implantable CRM devices market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 U.K. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 U.K. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Germany implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 France implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Italy implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Italy implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Spain implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Spain implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Denmark implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Sweden implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Norway implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Norway implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific implantable CRM devices market, by Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Japan implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 Japan implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 China implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 China implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 India implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 India implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Australia implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 44 Australia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 46 Thailand implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 South Korea implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 South Korea implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Latin America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 51 Latin America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Brazil implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 53 Brazil implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Argentina implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 55 Argentina implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 MEA implantable CRM devices market, by country, 2018 - 2030 (USD Million)
  • Table 57 MEA implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 58 MEA implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Africa implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 60 South Africa implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 UAE implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 64 UAE implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait implantable CRM devices market, by product, 2018 - 2030 (USD Million)
  • Table 66 Kuwait implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Participant's overview
  • Table 68 Financial performance
  • Table 69 Key companies undergoing expansions
  • Table 70 Key companies undergoing acquisitions
  • Table 71 Key companies undergoing collaborations
  • Table 72 Key companies launching new products/services
  • Table 73 Key companies undergoing partnerships
  • Table 74 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Implantable CRM devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Implantable Cardiac Rhythm Management (CRM) devices market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Implantable CRM devices market product outlook:
  • Fig. 14 Implantable CRM devices market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 17 Global conventional pacemakers market, 2018 - 2030 (USD Million)
  • Fig. 18 Global leadless pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 19 Global ICDS market, 2018 - 2030 (USD Million)
  • Fig. 20 Global single chamber ICDs market, 2018 - 2030 (USD Million)
  • Fig. 21 Global dual chamber ICDs market, 2018 - 2030 (USD Million)
  • Fig. 22 Global CRT market, 2018 - 2030 (USD Million)
  • Fig. 23 Global CRT-defibrillator market, 2018 - 2030 (USD Million)
  • Fig. 24 Global CRT-pacemaker market, 2018 - 2030 (USD Million)
  • Fig. 25 Implantable CRM devices market end-use outlook:
  • Fig. 26 Implantable CRM devices market: end-use movement analysis
  • Fig. 27 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Global specialty cardiac centers market, 2018 - 2030 (USD Million)
  • Fig. 29 Global others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional market place: Key takeaways
  • Fig. 31 North America implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 38 France implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 43 China implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 44 India implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 48 MEA implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia implantable CRM devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Market Participant Categorization
  • Fig. 52 Strategy mapping